Fractional Flow Reserve - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease
High-Resolution Cardiac Magnetic Resonance Imaging Techniques for the Identification of Coronary Microvascular Dysfunction
Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis
Impact of myocardial supply area on the transstenotic hemodynamics as determined by fractional flow reserve
Diagnostic Performance of the Instantaneous Wave-Free Ratio: Comparison With Fractional Flow Reserve
Influence of Heart Rate on FFR Measurements: An Experimental and Clinical Validation Study
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial
Combined Assessment of Stress Myocardial Perfusion Cardiovascular Magnetic Resonance and Flow Measurement in the Coronary Sinus Improves Prediction of Functionally Significant Coronary Stenosis Determined by Fractional Flow Reserve in Multivessel Disease
Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery disease
Lesion-Specific and Vessel-Related Determinants of Fractional Flow Reserve Beyond Coronary Artery Stenosis

|<< 1 2 3 4 5 6 7 8 9 >>|

Review Article

2018 Jan 1;3(1):87.

JOURNAL：JAMA Cardiol.

Article Link

Coronary Computed Tomography–Based Fractional Flow Reserve A Rapidly Developing Field

Baumann S, Renker M, Schoepf UJ.

2561

Keywords: Coronary Computed Tomography; Fractional Flow Reserve

ABSTRACT

Coronary computed tomography angiography (cCTA)–based fractional flow reserve (FFR-CT) is an evolving technology of disruptive potential to noninvasively determine the hemodynamic significance of a coronary artery stenosis. The systematic review by Cook et alprovides an excellent overview on the status of this innovative method. In their Methods section, the authors mention the FFR-CT algorithm approved by the US Food and Drug Administration in late 2014. However, technology and evidence in this field are rapidly evolving, which adds new facets to their discussion.